--- title: "MEDISAN: The company's drugs, Rosuvastatin capsules and Chlorpromazine for injection, are expected to win the bid" type: "News" locale: "en" url: "https://longbridge.com/en/news/263232080.md" description: "MEDISAN announced that the company recently participated in the bidding work organized by the National Organization for Drug Procurement Office for the 11th batch of national centralized drug procurement. The company's drugs, Rosuvastatin capsules and injectable Clonixin, are expected to win the bid in this centralized procurement" datetime: "2025-10-29T07:52:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263232080.md) - [en](https://longbridge.com/en/news/263232080.md) - [zh-HK](https://longbridge.com/zh-HK/news/263232080.md) generator: "portal-rs" --- # MEDISAN: The company's drugs, Rosuvastatin capsules and Chlorpromazine for injection, are expected to win the bid MEDISAN announced that the company recently participated in the bidding for the 11th batch of national centralized drug procurement organized by the National Organization for Drug Procurement Office. The company's drugs, Rosuvastatin capsules and injectable Clonixin, are expected to win the bid in this centralized procurement ### Related Stocks - [002900.CN](https://longbridge.com/en/quote/002900.CN.md) ## Related News & Research - [Texas could face an $826 million SNAP tab as federal costs shift to states](https://longbridge.com/en/news/296030745.md) - [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md) - [Bollywood stars told to stop appearing in surrogate ads in Indian state's food safety drive](https://longbridge.com/en/news/296102317.md) - ['Worrisome': AI is driving a looming market correction, central bank economists warn](https://longbridge.com/en/news/296226776.md) - [BitMart shutdown gets messy as staff speak out over unpaid wages](https://longbridge.com/en/news/296089549.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**